Stocks to Watch: Dish TV, Eicher, M&M

Total Page:16

File Type:pdf, Size:1020Kb

Stocks to Watch: Dish TV, Eicher, M&M Stocks to Watch: Dish TV, Eicher, M&M, Metropolis Health, Sun Pharma Friday, May 28, 2021 - Morning brief for the stock market: TOP EVENTS TODAY * Nifty 50 company detailing Jan-Mar earning: + Mahindra & Mahindra and Mahindra Vehicle Manufacturers, (Net profit seen 10.97 bln rupees vs 32.6 bln rupees loss year ago) * Jan-Mar earnings to be detailed by: 3M India, Incon Engineers, Rolcon Engineering Co, Action Construction Equipment, India Nippon Electricals, RSWM, AD Manum Finance, Indian Bank, Servoteach Industries, Aditya Birla Fashion and Retail, Indokem, Sharp Investments, Ador Multiproducts, IPCA Laboratories, Shish Industries, Ador Welding, ITD Cementation India, Shree Rama Newsprint, 1 Arvind Smartspaces, Jagran Prakashan, Shree Steel Wire Ropes, Associated Alcohols & Breweries, Jindal Poly Films, Shree Tulsi Online.Com, Aurionpro Solutions, Kama Holdings, Si Capital & Financial Services, Batliboi, Kanoria Chemicals & Industries, Sikozy Realtors, Bengal & Assam Co, Karur Vysya Bank, Sirca Paints India, Kovilpatti Lakshmi Roller Flour Blue Circle Services, SMS Pharmaceuticals, Mills, Lakshmi Electrical Control Bridge Securities, SRG Housing Finance, Systems, Calcom Vision, Max Healthcare Institute, SRU Steels, Camlin Fine Sciences, Mindteck India, Stanpacks India, Central Bank of India, Munoth Communication, Steel Exchange India, Chemo Pharma Laboratories, Munoth Financial Services, Steelcast, City Union Bank, NACL Industries, Sudal Industries, Classic Filaments, Navkar Corp, Sudarshan Chemical Industries, Confidence Futuristic Energetech, NCC, Sumitomo Chemical India, Confidence Petroleum India, Nesco, Sundaram Finance, Cyber Media (India), New Light Apparels, Supra Pacific Management Deepak Fertilisers & Petrochemicals Corp, Onmobile Global, T Spiritual World, Delta Manufacturing, Orient Green Power Co, Tashi India, Dilip Buildcon, Permanent Magnets, TCPL Packaging, Excel Industries, Polymac Thermoformers, The Ugar Sugar Works, Fiberweb India, Prataap Snacks, Time Technoplast, Force Motors, Pudumjee Paper Products, TV Today Network, 2 Genus Power Infrastructures, Rajapalayam Mills, Ujjivan Financial Services, Glenmark Pharmaceuticals, Rama Phosphates, Vinyoflex, GMM Pfaudler, REC, V-Mart Retail, Gorani Industries, Reliance Infrastructure, WEP Solutions, Gulf Oil Lubricants India, Renaissance Global, WPIL, Heidelbergcement India, RGF Capital Markets, Zuari Agro Chemicals * Board Meetings of: + Action Construction Equipment, to consider dividend + Arvind Smartspaces, to consider dividend + Associated Alcohols & Breweries, to consider dividend + Aurionpro Solutions, to consider dividend + Bengal & Assam Co, to consider dividend + City Union Bank, to consider dividend + Deepak Fertilisers & Petrochemicals Corp, to consider dividend + Dilip Buildcon, to consider dividend + Excel Industries, to consider dividend + Force Motors, to consider dividend + Glenmark Pharmaceuticals, to consider dividend + GMM Pfaudler, to consider dividend + Gulf Oil Lubricants India, to consider dividend 3 + Heidelbergcement India, to consider dividend + ITD Cementation India, to consider dividend + Jindal Poly Films, to consider dividend + Kama Holdings, to consider dividend + Kanoria Chemicals & Industries, to consider dividend + Karur Vysya Bank, to consider dividend + Kovilpatti Lakshmi Roller Flour Mills, to consider dividend + Lakshmi Electrical Control Systems, to consider dividend + Mahindra & Mahindra, to consider dividend + Mindteck India, to consider dividend + NACL Industries, to consider dividend + NCC, to consider dividend + Nesco, to consider dividend + Onmobile Global, to consider dividend + Permanent Magnets, to consider dividend + Polymac Thermoformers, to consider dividend + Prataap Snacks, to consider dividend + Pudumjee Paper Products, to consider dividend + Rajapalayam Mills, to consider dividend + Rama Phosphates, to consider dividend + Renaissance Global, to consider dividend 4 + Rolcon Engineering Co, to consider dividend + Sirca Paints India, to consider dividend + Sudarshan Chemical Industries, to consider dividend + Sumitomo Chemical India, to consider dividend + Sundaram Finance, to consider dividend + TCPL Packaging, to consider dividend + The Ugar Sugar Works, to consider dividend + Time Technoplast, to consider dividend + TV Today Network, to consider dividend * Annual General Meeting of: Automotive Stampings & Assemblies INDICATORS (previous session) * NSE provisional net buy/(sell) in bln rupees, May 27: FIIs (6.61), DIIs 1.12 * Institutional net buy/(sell) in bln rupees, May 25 and 26: FIIs 14.95 * FII NSE futures net buy/(sell) in bln rupee, May 27: index 26.37, stock (2.80) * Sensex: 51115.22, up 97.70 points; Nifty 50: 15337.85, up 36.40 points * Crude: $66.85/bbl; Rupee: 72.59/$1; Gold: $1,898.5/ounce; 10-year yield: 5.9873% GLOBAL MARKETS 5 * US : Benchmark indices ended mostly higher on Thursday on positive economic data as fewer-than-expected people applied for jobless claims in the country last week and the economy grew at an annualized pace of 6.4% in Jan-Mar, as estimated earlier. * Asia : Equities rose in early trade today, tracking positive cues from the US, where encouraging set of economic data boosted sentiment. DOMESTIC OUTLOOK * Indices are seen extending gains from Thursday on the back of improved global sentiment after data showed a fall in the US weekly jobless claims, and reports suggested that the US President is likely to propose a budget worth $6 trln. EARNINGS FOR JAN-MAR ==================== * EICHER MOTORS (Consol PAT 5.26 bln rupees, up 72.91% YoY Consol Revenue 29.40 bln rupees, up 33.16% YoY) * FINE ORGANIC INDUSTRIES (Consol PAT 317.91 mln rupees, down 7.46% YoY Consol Revenue 3.23 bln rupees, up 30.57% YoY) * GUJARAT PIPAVAV PORT (Consol PAT 653.9 mln rupees, up 20.79% YoY 6 Consol Revenue 1.93 bln rupees, up 19.44% YoY) * IRB INFRASTRUCTURE DEVELOPERS (Consol PAT 974.64 mln rupees, down 36.84% YoY Consol Revenue 16.06 bln rupees, up 1.35% YoY) * METROPOLIS HEALTHCARE (Consol PAT 613.46 mln rupees, up 295.96% YoY Consol Revenue 2.92 bln rupees, up 40.95% YoY) * REDINGTON (INDIA) (Consol PAT 3.03 bln rupees, up 153.78% YoY Consol Revenue 155.04 bln rupees, up 22.4% YoY) * SOLAR INDUSTRIES INDIA (Consol PAT 910.2 mln rupees, up 82.19% YoY Consol Revenue 7.91 bln rupees, up 44.55% YoY) * SUN PHARMACEUTICAL INDUSTRIES (Consol PAT 8.94 bln rupees, up 123.63% YoY Consol Revenue 85.23 bln rupees, up 4.13% YoY) 7 * UCO BANK (PAT 800.3 mln rupees, up 376.94% YoY NII 14.13 bln rupees, up 12.60% YoY) SECTOR NEWS =========== * FINANCE: The board of LTIDPL Indvit Services, which is the investment manager of IndInfravit Trust, has approved the allotment of non-convertible debentures aggregating up to 8.50 bln rupees on a private placement basis. * HEALTHCARE: Pfizer Inc may start distributing its COVID-19 vaccine in India by July, NITI Aayog member V.K. Paul said during a press conference. * TRADE: The government has approved the appointment of B.V.R. Subrahmanyam as commerce secretary from July. STOCKS ====== * ADANI ENTERPRISES: Integrated Core Strategies (Asia) sold shares of the company, ADANI TOTAL GAS, and ADANI TRANSMISSION via bulk deals on the National Stock Exchange. 8 * APOLLO HOSPITALS ENTERPRISE: Said that so far, it has administered 1 mln COVID- 19 vaccine doses across 80 locations through group hospitals in the country, and aims to take this number to 20 mln by September. * BHARAT ELECTRONICS: Integrated Core Strategies (Asia) sold 28.5 mln shares, or 1.2% stake, in the company at 148.43 rupees apiece via a bulk deal on the National Stock Exchange. * CADILA HEALTHCARE: Will likely apply for emergency usage authorisation for its COVID- 19 vaccine, ZyCov-D, in the next two weeks, Managing Director Sharvil Patel said. * CHOLAMANDALAM INVESTMENT AND FINANCE CO: Integrated Core Strategies (Asia) sold 7.9 mln shares, representing 0.96% stake in the company, at 537.32 rupees a share through a bulk deal on the National Stock Exchange. * DISH TV INDIA: Is considering a 10-bln-rupee rights issue. A board meeting on this is expected to be called soon, disclosed merchant banking sources. (BS) * HESTER BIOSCIENCES: Has signed a memorandum of understanding with Bharat Biotech International to invest 400 mln rupees and provide infrastructure to manufacture drug substance for Covaxin, one of the two COVID-19 vaccines being made in India. * HINDALCO INDUSTRIES: Has raised the prices of its aluminium ingots, billets and wire rods after cutting them five times in a row. The company raised prices by more than 1% or 2,500 rupees per tn with effect from Wednesday. 9 * HINDUSTAN UNILEVER: Will continue to focus on volume-led competitive growth even as it remains watchful of the second wave of COVID-19, the fast-moving consumer goods major said in its annual report for 2020-21 (Apr-Mar). * INFOSYS: Delivery capabilities have not been materially impacted due to the second wave of COVID-19 in India, Chief Executive Officer Salil Parekh said. Promoter S.D. Shibulal bought 722,545 shares, representing 0.02% stake, in the company from promoter Kumari Shibulal, who is also his wife, through a block deal on BSE. * JSW STEEL: Amid opposition from within the ruling BJP and cases pending in courts, the Karnataka cabinet on Thursday put on hold its earlier decision to sell 3,667 acres of land to the company in Ballari district. (PTI) * MARUTI SUZUKI INDIA: Is collaborating with manufacturers to boost production of oxygen generators in the country. (BS) * NATIONAL FERTILIZERS: The government has extended the
Recommended publications
  • Tla Hearing Board
    TLA HEARING BOARD Hearing Schedule from 01/10/2019 to 31/10/2019 Location: DELHI Hearing Timing : 10.30 am to 1.00 pm S.No TM No Class Hearing Proprietor Name Agent Name Mode of Date Hearing 1 3408747 41 01-10-2019 GAURAV SHARGA KSHITIJ MALHOTRA Physical 2 2713186 25 01-10-2019 TV TODAY NETWORK LTD. SAJAD SULTAN ADV., Physical 3 3404419 1 01-10-2019 TV TODAY NETWORK LIMITED SAJAD SULTAN ADV., Physical 4 3404420 2 01-10-2019 TV TODAY NETWORK LIMITED SAJAD SULTAN ADV., Physical 5 3425744 5 01-10-2019 MR. ASHISH KUMAR DUBEY LALJI ADVOCATES Physical 6 3426307 7 01-10-2019 SH. SHYAM VERMA. LALJI ADVOCATES Physical 7 3426308 11 01-10-2019 SH. SHYAM VERMA. LALJI ADVOCATES Physical 8 3426309 30 01-10-2019 PREM SINGH. LALJI ADVOCATES Physical 9 3426310 43 01-10-2019 PREM SINGH. LALJI ADVOCATES Physical 10 3426312 12 01-10-2019 SH. PAWAN KUMAR GUPTA. LALJI ADVOCATES Physical 11 3426314 12 01-10-2019 KSHITIZ GUPTA. LALJI ADVOCATES Physical 12 3427343 12 01-10-2019 MANINDER SINGH. LALJI ADVOCATES Physical 13 3427349 42 01-10-2019 MOBIN SIGNITY SOLUTIONS PRIVATE LIMITED. LALJI ADVOCATES Physical 14 3427353 6 01-10-2019 PANKAJ MITTAL. LALJI ADVOCATES Physical 15 3427356 35 01-10-2019 UNIQUE LIFE SCIENCES PVT. LTD. LALJI ADVOCATES Physical 16 3429261 9 01-10-2019 SAURABH GROVER. LALJI ADVOCATES Physical 17 3429262 7 01-10-2019 SH. RAM JAGAT. LALJI ADVOCATES Physical 18 3429263 11 01-10-2019 SH. RAM JAGAT. LALJI ADVOCATES Physical 19 3405602 5 01-10-2019 ALEXA PHARMACEUTICALS PRIVATE LIMITED ALEXA Physical PHARMACEUTICALS PRIVATE LIMITED 20 3417160 6 01-10-2019 SH.
    [Show full text]
  • 50 KW Offer Solar Copy 2
    21st Century Enviro Engineers Pvt.Ltd. Plot No. 120(10 Marla), COMPANY Industrial Area Phase II Chandigarh - 160002, India PROFILE www.21stcenturyenviro.com INTRODUCTION 21st CENTURY ENVIRO ENGINEERS PVT. LTD. is a Company dealing in the field of Environmental Engineering related activities. We are Registered Environmental Consultants of Pollution Control Board to Supply ETP’s, STP’s, APCD’s, Incinerators, Water Treatment Plants, Reverse Osmosis, Evaporators, Solid Waste Management and Rain Water Harvesting and to carry out EIA Studies . The Directors of the company are young Technocrats having versatile experience in this field. We have a back up of highly qualified and experienced technical team having versatile experience in Designing, Erection, Commissioning and Operation of different types of Effluent Treatment Plants. Our Managing Director himself is a Chemical Engineer with almost 25 Years Experience in this line and Technical Director is PhD. in Environmental Science with almost 30 Years working experience on various types of effluent treatment Technologies. Our team comprises of almost 150 people from different backgrounds e.g. Chemical, Environmental, Mechanical, Instrumentation, Civil, Accounts, Purchase, Marketing etc. We have our Marketing/ Design Office in Chandigarh and regional offices in Dhaka, Mumbai, New Delhi, Sikkim etc. and have our own testing Laboratory for Effluent/Water Testing and to study treatability of effluent on pilot scale. We have our own full-fledged manufacturing unit of Pollution Control Equipments in Village Kunjhal Baddi (HP). We also undertake annual operation and maintenance contracts and liasining services for the systems supplied by us. We are also Registered with CREST (Chandigarh Renewable Energy & Technology Promotion Society) and SECI (Solar Energy Corporation of India) for supplying Online/Offline Solar systems in Chandigarh, Himachal Pradesh, Uttarakhand, J&K, Punjab, Haryana, Delhi, Bihar etc.
    [Show full text]
  • Glenmark Pharmaceuticals (GLEPHA)
    Glenmark Pharmaceuticals (GLEPHA) CMP: | 483 Target: | 560 (16%) Target Period: 12 months BUY August 17, 2020 Subdued topline; margin expansion to the fore… Revenues stayed flattish growing just 0.9% YoY to | 2345 crore due to subdued growth of 1.6% in US to | 743 crore, 3.7% growth in domestic sales to | 780 crore. Europe business grew 12.8% YoY to | 274 crore. RoW markets de-grew 18.1% YoY to 212 crore. EBITDA margins improved 567 bps YoY to 20.4% mainly due to lower other expenditure. EBITDA grew Particulars 39.8% YoY to | 478 crore. Adjusted PAT grew 106.9% YoY to | 226 crore. P articular Am ount Delta vis-à-vis EBITDA was due to higher other income. Exceptional items in Market Capitalisation | 13615 crore Q1FY21 were | 28 crore on gain arising from sale of Vwash brand to HUL. Debt (FY20) | 4868 crore Result Update Result Cash & equivalent (FY20) | 1111 crore US growth dependent on new launches E V | 17371 crore 52 week H/L (|) 573/168 US generics comprise ~30% of total revenues. So far, the company has E quity capital | 28.2 crore Face value | 1 received approval for 164 ANDAs while another 44 are pending approval, of which 24 are Para IV applications. However, Glenmark’s derma portfolio is Key Highlights facing stiff pricing pressure in the US. Going ahead, traction from the newly commissioned US based Monroe facility will be the key determinant besides Q1FY21 revenues remained flattish sustained product launches. We expect the US to grow at 5.2% CAGR in due to subdued US growth amid FY20-22E to | 3479 crore on the back of new launches.
    [Show full text]
  • Hy Sun Missed the Pharma Rally: the Answer Is Hidden in a Bet Many Failed — Speciality Drugs - the Economic Times
    12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets News Industry RISE Politics Wealth MF Tech Jobs Opinion NRI Panache ET NOW More Aayush English Edition | E-Paper Tech Consumer Markets Corporate Governance Telecom + OTT Auto + Aviation Pharma Fintech + BFSI Economy Infra Environment Energy Business News › Prime › Pharma › Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Getty Images MARKETS hy Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Dilip Shanghvi, founder and managing director, Sun Pharmaceuticals Synopsis Sun Pharma is the only Indian company to have made some inroads into speciality drugs. What worries investors is high investments and uncertainties over ramp up in revenue. The stock can still see upside because of its current valuations, strong India business, and any positive surprises in US generic business. But it is crucial that its speciality bet pays off. BACK TO TOP https://economictimes.indiatimes.com/prime/pharma-and-healthcare/why-sun-missed-the-pharma-rally-the-answer-is-hidden-in-a-bet-many-failed-spe… 1/11 12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets NeCwasllI nitd uas trbyleRssISiEngP oilniti cdsisWgeuailthse fMoFr tTheceh InJodbisanOpinion NRI Panache ET NOW More pharmaceutical industry. The stocks of pharma companies have been on a tear since the beginning of the Covid-19 crisis.
    [Show full text]
  • DIA India ICH Day 2019 Enhancing Clinical Trial Outcomes with ICH 30Th August, 2019 | Taj Lands End | Mumbai, India
    DIA India ICH Day 2019 Enhancing Clinical Trial Outcomes with ICH 30th August, 2019 | Taj Lands End | Mumbai, India PROGRAMME COMMITTEE Today, the Indian pharmaceutical industry supplies approximately 20% of the world’s generic drugs and has the largest number of FDA-approved manufacturing facilities C. Michelle Limoli outside of the US. This industry has evolved during the past decade into innovative drug Senior International development, including new chemical and biological entities, biosimilars, and innovative Health Science Advisor differentiated products. At the same time, as healthcare costs continue to rise across the US FDA world, so does the global need for affordable, innovative healthcare. Against this backdrop, DIA India aims to create an initiative that will address the clinical and regulatory aspects Ramesh Jagannathan of drug development, through a comprehensive single day workshop on the latest ICH Associate Vice President guidelines and developments relevant for India. - R&D Biocon Ltd. Objective Anupama Ramkumar CEO and Principal The objective of this program is to provide a common platform for ICH trainers, regulatory Consultant authorities, academia, investigators, service providers, and the Indian biopharmaceutical Arkus Research Pvt. Ltd. industry, to deliberate upon and understand ICH guidelines and the most recent updates, impacting the drug development spectrum including key clinical, regulatory and quality Seema Pai aspects. Director - India Cluster Global Site & Study Take a look at our key topics for the event
    [Show full text]
  • Company Reliance Industries Limited Tata Consultancy Services
    Top 1000 Private Sector Companies (Rank-wise List) Company Reliance Industries Limited Tata Consultancy Services (TCS) Infosys Technologies Ltd Wipro Limited Bharti Tele-Ventures Limited ITC Limited Hindustan Lever Limited ICICI Bank Limited Housing Development Finance Corp. Ltd. TATA Steel Limited Ranbaxy Laboratories Limited HDFC Bank Ltd Tata Motors Limited Larsen & Toubro Limited (L&T) Satyam Computer Services Ltd. Maruti Udyog Limited Bajaj Auto Ltd. HCL Technologies Ltd. Hero Honda Motors Limited Hindalco Industries Ltd Reliance Energy Limited Grasim Industries Limited Jet Airways (India) Ltd. Sun Pharmaceuticals Industries Ltd Cipla Ltd. Gujarat Ambuja Cements Ltd. Videsh Sanchar Nigam Limited The Tata Power Company Limited Sterlite Industries (India) Ltd. Associated Cement Companies Ltd. Nestlé India Ltd. Hindustan Zinc Limited GlaxoSmithKline Pharmaceuticals Limited Siemens India Ltd. Motor Industries Company Limited Mahindra & Mahindra Limited UTI Bank Ltd. Zee Telefilms Limited Bharat Forge Limited ABB Limited i-Flex Solutions Ltd. Dr. Reddy's Laboratories Ltd. Nicholas Piramal India Limited Kotak Mahindra Bank Limited Reliance Capital Ltd. Ultra Tech Cement Ltd. Patni Computer Systems Ltd. Wockhardt Limited Indian Petrochemicals Corporation Limited Biocon India Limited Essar Oil Limited. Asian Paints Ltd. Dabur India Limited Jaiprakash Associates Limited JSW Steel Limited Tata Chemicals Limited Tata Tea Limited Tata Teleservices (Maharashtra) Limited The Indian Hotels Co. Ltd. Glenmark Pharmaceuticals Limited NIRMA Limited Jindal Steel & Power Ltd HCL Infosystems Ltd. Cadila Healthcare Limited Colgate-Palmolive (India) Limited The Great Eastern Shipping Company Limited Aventis Pharma India Ltd Ashok Leyland Limited Pantaloon Retail (India) Limited Indian Rayon And Industries Limited Financial Technologies (India) Ltd United Phosphorus Limited Matrix Laboratories Limited Sesa Goa Limited Lupin Ltd Cummins India Limited Crompton Greaves Limited.
    [Show full text]
  • Final Placement Report 2020-21
    FINAL PLACEMENT REPORT POST GRADUATE ProgrAM IN MANAGEMENT (PGP) 2019-21 12th BAtcH INDIAN INSTITUTE OF MANAGEMENT SHILLONG FOREWORD The Placement Committee of IIM Shillong takes immense pride in announcing the successful completion of the final placement season for the PGP batch of 2019-21. The stellar performance by the PGP participants stands testimony to the rapid progress made by IIM Shillong and has once again established IIM Shillong as the preferred choice for recruiters. We express our gratitude to our regular recruiters who have continuously believed in the mettle of our students and have furthered their association with us for another year to facilitate this mutually beneficial relationship. We are also grateful to our new recruiters, who have acknowledged the potential of our students and provided them with a plethora of opportunities. We appreciate the contribution of the entire IIM Shillong fraternity for their sustained assistance in the placement process. With continued support from students, recruiters, faculty, alumni, staff and management, we hope to carry this momentum onto the next academic year. Prof. Rohit Joshi Chairperson Placement Committee IIM Shillong BATCH PROFILE OF 2019-21 Education Background 9% 9% 9% 57% 198 16% Number 61% 39% of Students Male Female Engineering Arts Commerce & Finance Others Science Work Experience by Months Domain wise Work Experience Freshers 27% Information Technology & Analytics 47% 01-12 months 23% Consulting & Strategy 13% 19% Finance 23% 13-24 months 18% Sales & Marketing 11% 25-36
    [Show full text]
  • In the United States District Court for the District of Delaware
    IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE NOVARTIS PHARMACEUTICALS CORPORATION Plaintiff, v. Civil Action No. _____ APOTEX INC., APOTEX CORP., BIONPHARMA INC., EMCURE PHARMACEUTICALS, HERITAGE PHARMACEUTICALS INC., EZRA VENTURES, LLC, GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LIMITED, HEC PHARM CO., LTD., HEC PHARM USA INC., HETERO USA INC., HETERO LABS LIMITED UNIT-V, HETERO LABS LIMITED, PRINSTON PHARMACEUTICAL INC., STRIDES GLOBAL PHARMA PRIVATE LIMITED, STRIDES PHARMA, INC., ZYDUS PHARMACEUTICALS (USA) INC., and CADILA HEALTHCARE LIMITED Defendants. COMPLAINT Novartis Pharmaceuticals Corporation (“Novartis”) by its attorneys hereby alleges as follows: NATURE OF THE ACTION 1. This is an action for patent infringement arising under the patent laws of the United States, Title 35, United States Code and for declaratory judgment pursuant to the Declaratory Judgment Act, 28 U.S.C. §§ 2201, et seq . This action relates to Abbreviated New Drug Applications (“ANDAs”) filed by the above-named defendants with the U.S. Food and Drug Administration (“FDA”) for approval to engage in the commercial manufacture, use, or sale of Fingolimod 0.5 mg capsules, generic versions of Novartis’s GILENYA ® Capsules, 0.5 mg, prior to expiration of U.S. Patent No. 10,543,179 (“the ’179 patent”). ME1 32500579v.1 PARTIES A. Novartis 2. Novartis Pharmaceuticals Corporation is a corporation organized and existing under the laws of the State of Delaware, with its principal place of business in East Hanover, New Jersey. B. The Generic Defendants a) Apotex Inc.; Apotex Corp. 3. Upon information and belief, Defendant Apotex Inc. is a corporation organized and existing under the laws of Canada, having a principal place of business at 150 Signet Drive, Toronto, Ontario, Canada M9L 1T9.
    [Show full text]
  • Cipla Limited
    Cipla Limited Registered Office: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai – 400 013 Phone: (9122) 2482 6000, Fax: (9122) 2482 6893, Email: [email protected], Website: www.cipla.com Corporate Identity Number: L24239MH1935PLC002380 Annexure to the Board’s Report Particulars of employee remuneration for the financial year ended 31st March, 2017 As required under section 197(12) of the Companies Act, 2013, read with rule 5(2) and (3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. Employed throughout the year Name Designation Qualification Experience Age Date of Last employment Remuneration (in years) (in years) Employment (`) Abhayan Jawaharlal CLO - International B.Com, LLB 18 45 03-09-2012 Biocon Group 12,009,351 Ajay Luharuka Head - IPD and API Finance B.Com, MMS, CFA 21 44 11-07-1996 NIIT Limited 12,800,997 Anil Kumar Kartha Site Head - Patalganga B. Sc., B. Pharm 26 54 27-05-1991 Vysali Pharmaceuticals 12,779,636 Anita S Desai Head - Formulations ADL B. Sc., PGCT 22 49 18-07-1994 Bombay Drug House 11,775,986 Anuj Aggarwal Regional Head - EU B. Tech., MBA 13 35 08-07-2013 Mckinsey & Company 13,664,962 Anupam Kashiv Head - Shared Services MPBSE 27 51 18-11-2013 Cadbury Business Services 27,837,834 Balwinder Singh Sethi Regional Head – MENA M.A 19 52 09-01-2012 Promed Exports Pvt Ltd 15,543,864 Chandru Chawla Global Head - CNV, Strategy and B. Tech., PG 29 51 12-12-2011 Lupin Limited 33,920,416 M&A Debashis Sarkar Head - Marketing and APAC DTM B.
    [Show full text]
  • Joindre Capital Services Ltd. Sebi Regn No
    JOINDRE CAPITAL SERVICES LTD. SEBI REGN NO. INH000002061 / INZ000174034 DAILY REPORT 10th August 2018 India to release June industrial production; RBI to hold govt bonds, term repo, reverse repo auctions; State Bank of India, GAIL India, Hindalco Industries, Bosch India, Glenmark Pharmaceuticals, Indraprastha Gas, Sun TV among companies to report earnings. Prime Minister Narendra Modi, Oil Minister Dharmendra Pradhan to speak. WHAT TO WATCH: * India to Sell 3.49m Tons of Pulses to States at Subsidized Rates * India Must Name Chief Statistician At the Earliest, Panel Says * Vedanta Wins 41 blocks, ONGC 2 in Open Acreage Auction: Pradhan ** Vedanta’s Zambia Copper Unit Halts Section of Mine After Death * India Fraud Agency Arrests Former Bhushan Steel MD Neeraj Singal * Essar Signs 15-Year Gas Supply Contract With Gail: Statement * Power-Plant Lender in India Seeks $1 Billion in Dollar Bond Sale * Jet Air in Talks With Staff on Payroll Restructuring, Dube Says * Jet Airways Postpones Results Following Report of Cash Crunch * Templeton Favors Options to Ride Asia’s Best Stock Market Swings * Cryptokidnapping, or How to Lose $3 Billion of Bitcoin in India * The Leaders and Laggards Behind India’s World-Beat Growth * Modi’s Party Mulls Expanding Contentious India Citizenship Rules * Asia Stocks Edge Lower; Dollar Holds Advance: Markets Wrap * Global Funds Buy Net INR7.66b of India Equity Derivatives Thursday ** Global Funds Buy Net 3.71B Rupees of India Stocks Thursday: NSE ** Foreign Investors Buy Net INR9.17b of Indian Equities on Aug. 8 ECONOMIC DATA (All times India Time): * 5:30pm: India June Industrial Production y/y, est.
    [Show full text]
  • Market Masala… the Flavors That Influenced the Market This Week
    Go India Advisors Weekly Newsletter Market Masala… The flavors that influenced the market this week Week 24/CY20: 6th – 12th June 2020 1 Headlines this week Go India Advisors Another Day, another Deal; Powell GDP statement; Court – interest(ed) or not Weekly Newsletter Supreme Court clarified on the case of interest charged during moratorium. The issue now is limited to interest on interest deferred during moratorium. This is significant less Jio announced 7th and 8th sale of it's equity, this time 1.16% for threatening than question of interest waiver all together. Rs5683cr to Abu Dhabi Investment Authority (ADIA) and Banking sector took a sigh of relief and so did Indian additional 0.93% to Silver Lake Partners for Rs4546cr. Totalling upto 21.06% stake for Rs97885cr. More deals in offing are market. TPG(US$1.5bn), Saudi Arabia's Public Investment Fund (PIF) (US$1.5bn). And some rumours about either Google or Microsoft coming in. US Fed in it MPC on Thursday was dovish as expected. However more than expected downbeat assessment of the economy proved little bit too much for the stock markets to handle. This triggered the worst falls in stock market since 16th March. 13-06-2020 2 Global Markets – risk off Go India Advisors US Fed downbeat assessment of the economy, too hot for market to handle Weekly Newsletter Returns % Data for year 2020; except as specified 13-06-2020 3 Indian market – rally takes a breather Go India Advisors Volatility is the name of the game Weekly Newsletter Indian Markets for Week Ending 12th June 2020 For more information: Click on the image.
    [Show full text]
  • Group1 MAY-2021 APPROVED LIST
    Approved Securities List May 2021 Scrip Name ISIN Mindspace Business Parks REIT INE0CCU25019 Max Healthcare Institute Limited INE027H01010 Happiest Minds Technologies Limited INE419U01012 Route Mobile Limited INE450U01017 Computer Age Management Services Limited INE596I01012 Chemcon Speciality Chemicals Limited INE03YM01018 DSP BLACKROCK MICRO CAP FUND - REGULAR P INF740K01797 Kotak Mahindra MF - Kotak NV 20 ETF - DP INF174K01Z71 DSP BlackRock Liquid ETF (Daily Dividend INF740KA1EU7 ICICI Prudential Bank ETF INF109KC1E27 Sundaram Finance Holdings Limited INE202Z01029 ABB India Ltd INE117A01022 Aegis Logistics Ltd INE208C01025 Amara Raja Batteries Ltd INE885A01032 Hdfc Ltd INE001A01036 Bombay Dyeing & Manu. Company Ltd INE032A01023 Atul Ltd INE100A01010 Force Motors Ltd INE451A01017 Bajaj Finance Ltd INE296A01024 Balrampur Chini Mills Ltd INE119A01028 Banco Products India Ltd INE213C01025 Century Textiles & Industries Ltd INE055A01016 BASF India Ltd INE373A01013 Bata India Ltd INE176A01028 BEML Limited INE258A01016 Bharat Electronics Ltd INE263A01024 Bhansali Engineering Polymers Ltd INE922A01025 Blue Star Ltd INE472A01039 CESC Ltd INE486A01013 Chambal Fertilisers & Chemicals Ltd INE085A01013 Exide Industries Ltd INE302A01020 Cipla Ltd INE059A01026 CRISIL Limited INE007A01025 Dabur India Ltd INE016A01026 Bharat Heavy Electricals Ltd INE257A01026 Hindustan Petroleum Corporation Ltd INE094A01015 IFCI Ltd INE039A01010 Mahanagar Telephone Nigam Ltd INE153A01019 Mangalore Refinery & Petrochemicals Ltd INE103A01014 Chennai Petroleum Corporation
    [Show full text]